Cargando…

943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center

BACKGROUND: Actinomyces are human commensals with significant pathogenic potential. The aim of this study was to determine the epidemiology of Actinomycosis in a tertiary care cancer center and identify species most commonly associated with invasive disease. METHODS: We retrospectively reviewed all...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Atoum, Mohammad, Almyroudis, Nikolaos, Mullin, Katherine M, Segal, Brahm H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644790/
http://dx.doi.org/10.1093/ofid/ofab466.1138
_version_ 1784610167839522816
author El-Atoum, Mohammad
Almyroudis, Nikolaos
Mullin, Katherine M
Segal, Brahm H
author_facet El-Atoum, Mohammad
Almyroudis, Nikolaos
Mullin, Katherine M
Segal, Brahm H
author_sort El-Atoum, Mohammad
collection PubMed
description BACKGROUND: Actinomyces are human commensals with significant pathogenic potential. The aim of this study was to determine the epidemiology of Actinomycosis in a tertiary care cancer center and identify species most commonly associated with invasive disease. METHODS: We retrospectively reviewed all patients referred to our institution with suspected or documented solid or hematological malignancies and positive cultures for Actinomyces species from July 2007 to June 2020 (13 years). Species identification was performed by VITEK(®) automated system (bioMerieux Inc.). Probable invasive actinomycosis was defined as cases with consistent clinical presentation, suggestive radiographic findings, and a positive culture from a nonsterile site, but lack of histopathological confirmation. Proven invasive actinomycosis was defined as the presence of consistent clinical symptoms, suggestive radiographic findings, a positive culture and histopathological confirmation, or cultures from sterile site without histopathological confirmation. Contaminants were considered positive cultures from sterile or non-sterile site without evidence of disease. RESULTS: Of 233 cases with positive cultures 194 (83.3%) were considered contaminants and 39 (16.7%) diagnostic of invasive actinomycosis. Of 39 cases of invasive actinomycosis, 64% were documented in patients with solid tumors, 13% in hematological malignancy and 23% among individuals without proven malignancy, 25 (64%) were probable and 14 (36%) proven. Of patients with proven/probable actinomycosis 27 (69%) had polymicrobial growth. Abdominopelvic was the most frequent site of invasive actinomycosis. A. odontolyticus was the most common species isolated (41%) followed by A. meyeri (28%) in patients with invasive disease, and A. odontolyticus (42%) among contaminants. CONCLUSION: The majority of positive cultures for Actinomyces species were considered contaminants. In our cohort Invasive actinomycosis affected mainly patients with solid tumors. Abdominopelvic was the most common site of invasive disease. Species most commonly associated with invasive actinomycosis were A. odontolyticus followed by A. meyeri with A. israelii isolated less frequently. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86447902021-12-06 943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center El-Atoum, Mohammad Almyroudis, Nikolaos Mullin, Katherine M Segal, Brahm H Open Forum Infect Dis Poster Abstracts BACKGROUND: Actinomyces are human commensals with significant pathogenic potential. The aim of this study was to determine the epidemiology of Actinomycosis in a tertiary care cancer center and identify species most commonly associated with invasive disease. METHODS: We retrospectively reviewed all patients referred to our institution with suspected or documented solid or hematological malignancies and positive cultures for Actinomyces species from July 2007 to June 2020 (13 years). Species identification was performed by VITEK(®) automated system (bioMerieux Inc.). Probable invasive actinomycosis was defined as cases with consistent clinical presentation, suggestive radiographic findings, and a positive culture from a nonsterile site, but lack of histopathological confirmation. Proven invasive actinomycosis was defined as the presence of consistent clinical symptoms, suggestive radiographic findings, a positive culture and histopathological confirmation, or cultures from sterile site without histopathological confirmation. Contaminants were considered positive cultures from sterile or non-sterile site without evidence of disease. RESULTS: Of 233 cases with positive cultures 194 (83.3%) were considered contaminants and 39 (16.7%) diagnostic of invasive actinomycosis. Of 39 cases of invasive actinomycosis, 64% were documented in patients with solid tumors, 13% in hematological malignancy and 23% among individuals without proven malignancy, 25 (64%) were probable and 14 (36%) proven. Of patients with proven/probable actinomycosis 27 (69%) had polymicrobial growth. Abdominopelvic was the most frequent site of invasive actinomycosis. A. odontolyticus was the most common species isolated (41%) followed by A. meyeri (28%) in patients with invasive disease, and A. odontolyticus (42%) among contaminants. CONCLUSION: The majority of positive cultures for Actinomyces species were considered contaminants. In our cohort Invasive actinomycosis affected mainly patients with solid tumors. Abdominopelvic was the most common site of invasive disease. Species most commonly associated with invasive actinomycosis were A. odontolyticus followed by A. meyeri with A. israelii isolated less frequently. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644790/ http://dx.doi.org/10.1093/ofid/ofab466.1138 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
El-Atoum, Mohammad
Almyroudis, Nikolaos
Mullin, Katherine M
Segal, Brahm H
943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center
title 943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center
title_full 943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center
title_fullStr 943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center
title_full_unstemmed 943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center
title_short 943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center
title_sort 943. epidemiology of actinomycosis in a tertiary care cancer center
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644790/
http://dx.doi.org/10.1093/ofid/ofab466.1138
work_keys_str_mv AT elatoummohammad 943epidemiologyofactinomycosisinatertiarycarecancercenter
AT almyroudisnikolaos 943epidemiologyofactinomycosisinatertiarycarecancercenter
AT mullinkatherinem 943epidemiologyofactinomycosisinatertiarycarecancercenter
AT segalbrahmh 943epidemiologyofactinomycosisinatertiarycarecancercenter